Drug General Information
Drug ID
D02LWU
Former ID
DAP001549
Drug Name
Pralatrexate
Synonyms
Folotyn (TN)
Drug Type
Small molecular drug
Indication Peripheral T-cell lymphoma; Breast cancer [ICD9: 202.7, 174, 175; ICD10:C84.4, C50] Approved [530677], [541920], [551871]
Company
Allos Therapeutics
Structure
Download
2D MOL

3D MOL

Formula
C23H23N7O5
InChI
InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1
InChIKey
OGSBUKJUDHAQEA-WMCAAGNKSA-N
CAS Number
CAS 146464-95-1
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
L01BA05
Target and Pathway
Target(s) Dihydrofolate reductase Target Info Inhibitor [530677]
PathWhiz Pathway Folate Metabolism
Pterine Biosynthesis
Reactome E2F mediated regulation of DNA replication
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Metabolism of folate and pterines
G1/S-Specific Transcription
References
Ref 530677Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.
Ref 541920(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6840).
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 530677Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.